Center for Immunotherapy and Cell-Based Technologies

Novosibirsk — Kaliningrad — Moscow — Irkutsk
Main

Gastric cancer

Xenovaccinotherapy for cancer

http://www.medicalnewstoday.com/rss/cancer-oncology.xmlhttp://www.medicalnewstoday.com/rss/immune_system.xmlhttp://www.medicalnewstoday.com/rss/multiple_sclerosis.xmlhttp://www.medicalnewstoday.com/rss/stem_cell_research.xml

  • docid_1259.pageCache.php
  • docid_2.pageCache.php
  • docid_255.pageCache.php
  • docid_294.pageCache.php
  • docid_312.pageCache.php
  • docid_313.pageCache.php
  • docid_314.pageCache.php
  • docid_315.pageCache.php
  • docid_879.pageCache.php

06.01.2017 A comprehensive analysis of 559 esophageal and gastric cancer samples, collected from patients around the world, suggests the two main types of esopha...

01.07.2016 Phase III trial finds no significant difference in overall survival.Post-operative treatment intensification with chemoradiotherapy does not achieve b...

21.04.2016 Diagnosis of gastric cancer in the early stages is difficult because of the lack of simple and cheap methods of inspection and specific markers of ga...

14.03.2016 Researchers report photoimmunotherapy to be effective against elusive gastric cancer cells following transduction with the gene that expresses the ext...

14.01.2016 The gastric pathogen Helicobacter pylori is highly adapted to survival in the human stomach and responsible for the majority of peptic ulcer and gastr...

16.11.2015 The prognosis for patients with gastric cancer is poor. In western countries even patients with localized gastric or gastro-esophageal junction adenoc...

29.10.2015 Genomic fingerprint can highlight which breast, ovarian, pancreatic and gastric cancers are likely to respond to treatmentGastric cancer, otherwise kn...

29.10.2015 Genomic fingerprint can highlight which breast, ovarian, pancreatic and gastric cancers are likely to respond to treatmentGastric cancer, otherwise kn...

10.09.2015 Gastric cancer poses a significant health problem in developing countries and is typically associated with late-stage diagnosis and high mortality....

24.07.2015 Researchers have found that treatment for a common gut bacteria could have a small benefit in preventing the development of gastric cancer....


Immunotherapy for cancer

An active specific immunotherapy (vaccinotherapy) is a strategy using tumor-associated antigens for including antitumor immune responses. The small structural distinctions of the xenogenic tumor-associated antigens from their human analogues render these antigens highly immunogenic and capable of including immune-mediated, antitumor responses in a patient not only at early, but also at advanced stages of disease, when tumor-derived immunosuppression is significant. Tumor-specfic immunotherapy is able to generate a selective and long-term antitumor effect. Such a therapy has no complications attributable to chemotherapy.

Xenovaccinotherapy for cancer